We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPR:NYSETapestry, Inc. Analysis

Data as of 2026-09-01 - not real-time

$122.72

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Tapestry, Inc. is priced at $122.72, and its moving averages give no clean directional read — the structure is neutral. It has lost 13.7% over the past 30 days. With RSI at 31.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $120.31 and resistance around $164.80.
On valuation the read is fair — an earnings multiple of 16.9, absent a reliable peer benchmark. Consensus targets land 36.4% above where the shares trade now. Revenue is growing at 8.9% on a 19.1% profit margin. The 1.50% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 62.2%, a beta of 1.18 and a maximum drawdown of 25.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Tapestry NYSE: TPR , whose Coach brand Krakoff himself helped build, is the most direct equity expression of that...Tapestry Inc TPR exceeds three-year targets two years early, with strong Coach performance and robust shareholder...Seeking Alpha28dTapestry: A Better Business In A Better Industry Rating Upgrade Tapestry is upgraded to Buy as Coach...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 138.03
  • MACD momentum is negative
  • 30-day price change of -13.7%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 138.03
  • Analyst targets imply +36.4% versus the current price
  • 30-day volatility of 62.2%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +36.4% versus the current price
  • Profit margin of 19.1% is healthy
  • P/E ratio of 16.9

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin19.09%
P/E Ratio16.9
ROE197.13%
ROA17.54%
Debt/Equity571.61
P/B Ratio35.5
Op. Cash Flow$2.0B
Free Cash Flow$1.4B

Technical Analysis

TrendNeutral
RSI31.7
Support$120.31
Resistance$164.80
MA 20$138.02
MA 50$142.35
MA 200$138.03
MACDBearish
VolumeDecreasing
Fear & Greed Index94.09

Valuation

Fair Value$116.08
Target Price$167.40
Upside/Downside36.41%
GradeFair
TypeBlend
Dividend Yield1.50%

Risk Assessment

Beta1.18
Volatility62.17%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.